Catalogs from Rockland Immunochemicals
Immunology Antibodies
Enhance immune system and infectious disease research with Rockland’s extensive collection of primary antibodies that cover key areas of immunology, including cell surface markers, cytokine antibodies, T cell receptors, MHC molecules, and their protein partners. Rockland produces antibodies to specific diseases like Lyme disease, SARS, and influenza, including several monoclonal antibodies to H5N1, a subtype of Influenza A. Their selection of antibodies also includes a diverse set of specific antibodies to modified proteins, such as phospho-specific and methylation-specific antibodies. Rockland also caters to the complement system, immunotherapy, autoimmune diseases, and immuno-oncology. Released October 2025.
Cancer Research
Accelerate your cancer research with Rockland’s comprehensive portfolio of high-quality reagents and cell lines. From Melanoma Cell Lines to key signaling pathway targets such as ATM, AKT, MEK/ERK, PARP1, and PTM, Rockland's products are designed to support precision and reproducibility in every experiment. Explore their trusted selection of NCI standards, GFP & epitope reagents, and essential supporting tools—all developed to help you uncover new insights in cancer biology and therapeutic discovery. Released October 2025.
DyLight™ Fluorescent Dye Conjugates
DyLight™ conjugated antibodies are high-performance fluorescent conjugates for use in primary or secondary antibody assays such as fluorescence microscopy, flow cytometry, western blotting, ELISA, high-content screening, multiplex assays, and other array platforms. The antibodies are offered as highly functional conjugates with bright emission spectra that match the principal output wavelengths of common fluorescence instrumentation. Updated October 2025.
Neuroscience Antibodies
The neuroscience antibodies by our partner Rockland Immunochemicals exhibit high specificity, sensitivity, and reproducibility. These antibodies are routinely used for characterization of neural development, stem cell and differentiation, neural transmission, neurodegenerative disease, and neuroinflammation. Discover antibodies directed against different targets including AKT or different GABAA receptor subunits, which can be used in several applications such as ELISA, Western blot or immunohistochemistry. For a number of antibodies, trial sizes are available. When buying Rockland antibodies, you will get top-class antibodies from a leading manufacturer. Updated October 2025.
7 Considerations for Choosing the Best Secondary Antibody
Choosing the right secondary antibody is essential for accurate, reproducible results. Rockland highlights seven key factors: host species compatibility, reporter choice for optimal detection, cross-adsorbed antibodies for higher specificity, and class/subclass matching for precision. Consider F(ab’)₂ or Fab fragments to reduce background, and select between affinity-purified or IgG fraction antibodies to fit your assay needs. Rockland provides the quality and expertise you can trust for every application. Released October 2025.
In Vitro Diagnostic Products
For over 50 years Rockland has provided a dedicated portfolio of general purpose reagents used to collect, prepare, and examine specimens for a broad range of diagnostic applications, including anti-RBC antibodies, secondary antibodies, gamma globulins, buffers, stabilizers, diluents and substrates. Similarly, Rockland has produced and validated monoclonal antibodies against biomarker proteins that can be used as analyte-specific reagents, which are available for licensing. All IVD raw materials and reagents are produced and manufactured following Rockland’s strict quality system and can be further modified to meet specific product and quality needs that clients require. Updated October 2025.
Post-Translational Modification Antibodies
PTM antibodies target the chemical changes on proteins, DNA, and RNA as a result of an covalent attachment. PTM antibodies can also be used to identify and purify protein-protein, protein-DNA, and/or protein-RNA complexes containing the modified protein. Although the generation of PTM antibodies is challenging, Rockland scientists have developed proprietary methods for the development of highly-specific PTM antibodies that can be used in a wide range of in vitro and in vivo studies of a modified protein. Updated October 2025.
Lyme Disease
Current Lyme disease tests often produce false results due to limited antigen detection and patient variability. Borrelia burgdorferi changes its protein expression throughout infection, making single-antigen assays like ELISA unreliable. Rockland’s innovative solution targets all stages of infection—early, latent, and chronic—using 14 precisely engineered Borrelia-specific antigens. This multiplex diagnostic approach accurately detects both IgM and IgG antibodies, offering superior sensitivity and specificity. In direct comparisons, the Rockland Test outperformed the C6 VlsE ELISA, delivering more accurate and reliable results. Updated October 2025.
TrueBlot®
Rockland’s TrueBlot® line of products consist of both IP beads and monoclonal secondary antibodies that can be used together or separately to achieve exceptional results in protein purification and detection. Simply substitute TrueBlot® secondary antibodies with your current conventional secondary antibody in protocols involving immunoblotting of immunoprecipitated proteins or when studying post-translational protein modifications (phosphorylation) and protein-protein interactions. TrueBlot® secondary antibodies avoid interference from denatured antibody fragments and non-specific binding of other sample contaminants, providing unhindered detection of blotted target bands. Updated October 2025.
Antibodies & Reagents for Consistent Results
The antibodies and antibody-based tools made by Rockland undergo a rigorous barrage of quality control tests. The company's scientists validate the performance of antibodies by different assays including ELISA, Western blotting, flow cytometry and immunohistochemistry. Because Rockland produces their own antiserum, at their animal facilities, and purify and test each antibody in their laboratories, they can guarantee the quality of every product. Rockland is one of the most referenced companies in the industry and continues to collaborate to develop new products such as isoform-specific AKT antibodies, GFP and RFP antibodies, and epigenetic secondary antibodies validated by the most demanding assays. Rockland products are guaranteed to give predictable, repeatable results (NOTE: Rockland blood products not availabe through Biomol). Released June 2023.